Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL793323 | 0.98 | DNM1 (0.52) | DNM1KDM4EPAOXHPGDHTT | |
| Methylamine SCHEMBL28500749 | 0.96 | DNM1 (0.50) | DNM1KDM4EPAOXHPGDHTT | |
| SCHEMBL20501368 | 0.93 | KDM4E (0.49) | DNM1KDM4EPAOXTSHRALDH1A1 | |
| SCHEMBL27503353 | 0.88 | DNM1 (0.53) | DNM1KDM4EPAOXHPGDHTT | |
| SCHEMBL1414877 | 0.85 | — | — | |
| SCHEMBL18339127 | 0.84 | SIGMAR1 (0.41) | DNM1 | |
| Hydrochloric Acid SCHEMBL17022764 | 0.83 | DNM1 (0.47) | DNM1KDM4EHTTALDH1A1 | |
| SCHEMBL78355 | 0.83 | KDM4E (0.59) | DNM1KDM4EPAOXHPGDHTT | |
| SCHEMBL36169 | 0.83 | DNM1 (0.55) | DNM1KDM4EPAOXHPGDHTT | |
| SCHEMBL9702900 | 0.82 | KDM4E (0.54) | DNM1KDM4EPAOXHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773121-B2 | Antiviral compounds | VIROVAX LLC (US) | 2023-10-03 | — | — | US | claimed |
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | VIROVAX LLC | 2021-08-05 | — | — | US | claimed |
| EP-3609888-A1 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | Metacrine, Inc. (US) | 2020-02-19 | — | — | EP | claimed |
| US-10470465-B2 | Glomus iranicum var. tenuihypharum var. nov. strain and use thereof as biostimulant | SYMBORG, S.L. (ES) | 2019-11-12 | — | — | US | claimed |
| WO-2018170182-A1 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | METACRINE, INC. (US) | 2018-09-20 | — | — | WO | claimed |
| EP-2667718-B1 | COMPOSITION COMPRISING AN ELICITOR OF THE PLANT IMMUNE SYSTEM | FYTOFEND S A (BE) | 2016-03-30 | — | — | EP | claimed |
| CN-102498095-A | Indoline derivatives | TOKYO INST TECH | 2012-06-13 | — | — | CN | claimed |
| US-8173653-B2 | Pyridiazinone derivatives for the treatment of tumours | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2012-05-08 | — | — | US | claimed |
| EP-1960370-B1 | PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT | MERCK PATENT GMBH (DE) | 2011-10-05 | — | — | EP | claimed |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MERCK PATENT GESELLSCHAFT (DE) | 2008-11-27 | — | — | US | claimed |
| CN-1191257-C | Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2005-03-02 | — | — | CN | claimed |
| EP-0874809-B1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2003-08-27 | — | — | EP | claimed |
| CN-1437604-A | Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2003-08-20 | — | — | CN | claimed |
| EP-0946093-B1 | FUNGICIDAL COMPOSITIONS BASED ON (N-PHENYLACETYL-N-2,6-XYLYL)METHYL ALANINATE | ISAGRO SPA (IT) | 2002-08-28 | — | — | EP | claimed |
| US-6239175-B1 | Carbamoyloxy derivatives of mutiline and their use as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-29 | — | — | US | claimed |
| US-5480989-A | Carbamates of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-02 | — | — | US | claimed |
| US-5227401-A | ETHYNYL ALANINE AMINO DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION | G. D. SEARLE & CO. (US) | 1993-07-13 | — | — | US | claimed |
| EP-0280348-B1 | FUNGICIDAL COMPOSITIONS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-09-23 | — | — | EP | claimed |
| US-4400312-A | WATER, A HYDROXIDE, AND A DIALKYLAMINO DITHIO CARBAMIC ACID, A MERCAPTO ALKANONE, OR A 3-HYDROXYTHIETANE | PHILLIPS PETROLEUM COMPANY (US) | 1983-08-23 | — | — | US | claimed |
| US-11945806-B2 | Stabilization of amyloidogenic immunoglobulin light chains | THE SCRIPPS RESEARCH INSTITUTE | 2024-04-02 | — | — | US | disclosed |
| EP-3509418-B1 | SEED COATINGS COMPRISING PESTICIDE | TERRAMERA EXCO HOLDINGS LTD (CA) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023154818-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MODERNATX, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| WO-2023076605-A1 | LIPID AMINES | MODERNATX, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| US-20230109183-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | ARBUTUS BIOPHARMA CORPORATION (US) | 2023-04-06 | — | — | US | disclosed |
| US-20220204485-A1 | STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS | THE SCRIPPS RESEARCH INSTITUTE | 2022-06-30 | — | — | US | disclosed |
| EP-3988104-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | Arbutus Biopharma Corporation (CA) | 2022-04-27 | — | — | EP | disclosed |
| EP-3950692-A1 | NOVEL TRICYCLIC COMPOUNDS | AbbVie Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-3946604-A1 | BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS | The Scripps Research Institute (US) | 2022-02-09 | — | — | EP | disclosed |
| US-11236071-B1 | Farnesoid X receptor agonists and uses thereof | METACRINE, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3473611-B1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | ARBUTUS BIOPHARMA CORP (CA) | 2021-10-20 | — | — | EP | disclosed |
| CN-109053742-B | Novel tricyclic compounds | ABBVIE 公司 | 2021-06-15 | — | — | CN | disclosed |
| US-20210061813-A1 | NOVEL TRICYCLIC COMPOUNDS | ABBVIE INC. (US) | 2021-03-04 | — | — | US | disclosed |
| EP-3774722-A1 | OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO | Epiodyne, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020205683-A1 | BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-10-08 | — | — | WO | disclosed |
| US-20200306378-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | ARBUTUS BIOPHARMA CORPORATION (CA) | 2020-10-01 | — | — | US | disclosed |
| EP-3677567-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | Arbutus Biopharma Corporation (CA) | 2020-07-08 | — | — | EP | disclosed |
| US-10561732-B2 | Trialkyl cationic lipids and methods of use thereof | ARBUTUS BIOPHARMA CORPORATION (CA) | 2020-02-18 | — | — | US | disclosed |
| WO-2019195634-A1 | OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO | EPIODYNE, INC. (US) | 2019-10-10 | — | — | WO | disclosed |
| US-20190254285-A1 | SODIUM PHOSPHITE COMBINATIONS | CERADIS PATENT B.V. (NL) | 2019-08-22 | — | — | US | disclosed |
| EP-3509418-A1 | SEED COATINGS COMPRISING PESTICIDE | Exosect Limited (GB) | 2019-07-17 | — | — | EP | disclosed |
| EP-3503732-A1 | SODIUM PHOSPHITE COMBINATIONS | Arec Crop Protection B.V. (NL) | 2019-07-03 | — | — | EP | disclosed |
| EP-3233790-B1 | CHEMICAL BLOWING AGENT AND THERMALLY EXPANDABLE THERMOPLASTIC COMPOSITION | SIKA TECH AG (CH) | 2019-06-26 | — | — | EP | disclosed |
| CN-109673655-A | The bactericidal composition of the amine of bacterium containing figured silk fabrics and its application | 陕西标正作物科学有限公司 | 2019-04-26 | — | — | CN | disclosed |
| US-RE47221-E1 | Tricyclic compounds | ABBVIE INC. (US) | 2019-02-05 | — | — | US | disclosed |
| EP-2817287-B1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | ARBUTUS BIOPHARMA CORP (CA) | 2018-10-03 | — | — | EP | disclosed |
| WO-2018149816-A1 | COMPOSITIONS FOR APPLICATION TO AERIAL PARTS OF PLANTS | EXOSECT LIMITED (GB) | 2018-08-23 | — | — | WO | disclosed |
| WO-2018044161-A1 | SODIUM PHOSPHITE COMBINATIONS | AREC CROP PROTECTION B.V. (NL) | 2018-03-08 | — | — | WO | disclosed |
| CN-105165883-B | Fungicidal mixture based on azoles and pyrimidine radicals amine | 巴斯夫欧洲公司 | 2018-01-30 | — | — | CN | disclosed |
| EP-3266786-A1 | NOVEL TRICYCLIC COMPOUNDS | AbbVie Inc. (US) | 2018-01-10 | — | — | EP | disclosed |
| WO-2017216193-A1 | SEED COATINGS COMPRISING PESTICIDE | EXOSECT LIMITED (GB) | 2017-12-21 | — | — | WO | disclosed |
| CN-107075712-A | Non-amphoteric, quaternizable and water-soluble polymers for modifying the surface charge of solid particles | 巴斯夫欧洲公司 | 2017-08-18 | — | — | CN | disclosed |
| US-20170204076-A1 | SYNTHESIS AND USE OF AMINO LIPIDS | SCREENFECT GMBH (DE) | 2017-07-20 | — | — | US | disclosed |
| US-20170007702-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2017-01-12 | — | — | US | disclosed |
| WO-2016174062-A1 | METHOD AND KIT FOR DISCHARGING AGROCHEMICAL PRODUCTS FROM TRANSPORT CONTAINERS. RELATED PRODUCTS | ARYSTA LIFESCIENCE BENELUX SPRL (BE) | 2016-11-03 | — | — | WO | disclosed |
| US-20160222020-A1 | NOVEL TRICYCLIC COMPOUNDS | ABBVIE INC. (US) | 2016-08-04 | — | — | US | disclosed |
| CN-103416416-B | Bactericidal composition containing tiadinil | Shaanxi Welch Crop Protection Co.,Ltd. (CN) | 2016-05-18 | — | — | CN | disclosed |
| WO-2016005318-A1 | SYNTHESIS AND USE OF AMINO LIPIDS | INCELLA GMBH (DE) | 2016-01-14 | — | — | WO | disclosed |
| EP-2966068-A1 | Synthesis and use of amino lipids | Incella GmbH (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-2961736-A1 | INHIBITORS OF HISTONE DEMETHYLASES | Epitherapeutics ApS (DK) | 2016-01-06 | — | — | EP | disclosed |
| WO-2015057847-A1 | CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS | CERULEAN PHARMA INC. (US) | 2015-04-23 | — | — | WO | disclosed |
| EP-2854527-A1 | STORAGE AIDS COMPRISING PLANT PROTECTANTS AND THEIR USE | se ma Gesellschaft für Innovationen mbH (DE) | 2015-04-08 | — | — | EP | disclosed |
| EP-2817345-A1 | CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS | Cerulean Pharma Inc. (US) | 2014-12-31 | — | — | EP | disclosed |
| EP-2817287-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | Protiva Biotherapeutics Inc. (CA) | 2014-12-31 | — | — | EP | disclosed |
| WO-2014131777-A1 | INHIBITORS OF HISTONE DEMETHYLASES | EPITHERAPEUTICS APS (DK) | 2014-09-04 | — | — | WO | disclosed |
| EP-1521733-B1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | PFIZER PROD INC (US) | 2014-08-20 | — | — | EP | disclosed |
| US-20140037573-A1 | CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS | CERULEAN PHARMA INC (US) | 2014-02-06 | — | — | US | disclosed |
| WO-2013175461-A1 | STORAGE AIDS COMPRISING PLANT PROTECTANTS AND THEIR USE | se ma Gesellschaft für Innovationen mbH (DE) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013126803-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | PROTIVA BIOTHERAPEUTICS INC. (CA) | 2013-08-29 | — | — | WO | disclosed |
| WO-2013126564-A1 | CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS | CERULEAN PHARMA INC. (US) | 2013-08-29 | — | — | WO | disclosed |
| US-20130216497-A1 | NOVEL TRICYCLIC COMPOUNDS | ABBOTT LABORATORIES | 2013-08-22 | — | — | US | disclosed |
| EP-2616443-A1 | PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS | Exelixis, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| US-8426411-B2 | Tricyclic compounds | ABBOTT LABORATORIES (US) | 2013-04-23 | — | — | US | disclosed |
| EP-2506716-A1 | NOVEL TRICYCLIC COMPOUNDS | Abbott Laboratories (US) | 2012-10-10 | — | — | EP | disclosed |
| CN-102498095-A | Indoline derivatives | TOKYO INST TECH | 2012-06-13 | — | — | CN | disclosed |
| US-8173653-B2 | Pyridiazinone derivatives for the treatment of tumours | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2012-05-08 | — | — | US | disclosed |
| WO-2012037132-A1 | PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS | EXELIXIS, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| US-20110311474-A1 | Novel Tricyclic Compounds | ABBOTT LABORATORIES (US) | 2011-12-22 | — | — | US | disclosed |
| US-7553877-B2 | Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma | PFIZER, INC. (US) | 2009-06-30 | — | — | US | disclosed |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MERCK PATENT GESELLSCHAFT (DE) | 2008-11-27 | — | — | US | disclosed |
| US-7138406-B2 | Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders | PFIZER, INC. (US) | 2006-11-21 | — | — | US | disclosed |
| US-20060247264-A1 | Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma | PFIZER INC | 2006-11-02 | — | — | US | disclosed |
| US-20060159772-A1 | Fungicidal compositions | ISAGRO S.P.A. (IT) | 2006-07-20 | — | — | US | disclosed |
| EP-1565057-A2 | FUNGICIDAL COMPOSITIONS CONTAINING AT LEAST ONE SALT OF PHOSPHOROUS ACID AND AT LEAST A SECOND FUNGICIDAL COMPONENT | ISAGRO S.p.A. (IT) | 2005-08-24 | — | — | EP | disclosed |
| EP-1521733-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | Pfizer Products Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| CN-1191257-C | Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2005-03-02 | — | — | CN | disclosed |
| EP-1370141-B1 | NOVEL FUNGICIDE COMPOSITIONS BASED ON PYRIDYLMETHYLBENZAMIDE AND PROPAMOCARB DERIVATIVE | BAYER CROPSCIENCE SA (FR) | 2005-01-05 | — | — | EP | disclosed |
| US-20040138262-A1 | Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders | PFIZER INC. | 2004-07-15 | — | — | US | disclosed |
| WO-2004047540-A2 | FUNGICIDAL COMPOSITIONS CONTAINING AT LEAST ONE SALT OF PHOSPHOROUS ACID AND AT LEAST A SECOND FUNGICIDAL COMPONENT | ISAGRO S.P.A. (IT) | 2004-06-10 | — | — | WO | disclosed |
| EP-1383737-A1 | PROCESS FOR THE PREPARATION OF ALKYL-N-(3-DIMETHYLAMINO)ALKYLCARBAMATES | Bayer CropScience GmbH (DE) | 2004-01-28 | — | — | EP | disclosed |
| WO-2004005229-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | PFIZER PRODUCTS INC. (US) | 2004-01-15 | — | — | WO | disclosed |
| US-6667414-B2 | Renin inhibitors; hypertensive agents | PHARMACIA CORPORATION | 2003-12-23 | — | — | US | disclosed |
| EP-1370141-A1 | NOVEL FUNGICIDE COMPOSITIONS BASED ON PYRIDYLMETHYLBENZAMIDE AND PROPAMOCARB DERIVATIVE | Bayer CropScience S.A. (FR) | 2003-12-17 | — | — | EP | disclosed |
| EP-0874809-B1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2003-08-27 | — | — | EP | disclosed |
| CN-1437604-A | Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2003-08-20 | — | — | CN | disclosed |
| US-20030144542-A1 | Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure | HANSON GUNNAR J (US) | 2003-07-31 | — | — | US | disclosed |
| US-20030135066-A1 | Use of propargyl glycine amino propargyl diol compounds for treatment of congestive heart failure | HANSON GUNNAR J (US) | 2003-07-17 | — | — | US | disclosed |
| US-20030130522-A1 | Use of propargyl glycine amino propargyl diol compounds for prevention of hypertension | HANSON GUNNAR J (US) | 2003-07-10 | — | — | US | disclosed |
| EP-1292597-A1 | CARBAMATE AND THIOCARBAMATE PODOPHYLLOTOXIN DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Les Laboratoires Servier (FR) | 2003-03-19 | — | — | EP | disclosed |
| WO-2002090322-A1 | PROCESS FOR THE PREPARATION OF ALKYL-N-(3-DIMETHYLAMINO)ALKYLCARBAMATES | BAYER CROPSCIENCE GMBH (DE) | 2002-11-14 | — | — | WO | disclosed |
| WO-2002069714-A1 | NOVEL FUNGICIDE COMPOSITIONS BASED ON PYRIDYLMETHYLBENZAMIDE AND PROPAMOCARB DERIVATIVE | BAYER CROPSCIENCE S.A. (FR) | 2002-09-12 | — | — | WO | disclosed |
| WO-2001098307-A1 | CARBAMATE AND THIOCARBAMATE PODOPHYLLOTOXIN DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2001-12-27 | — | — | WO | disclosed |
| US-6239175-B1 | Carbamoyloxy derivatives of mutiline and their use as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-29 | — | — | US | disclosed |
| EP-1095940-A2 | Derivatives of 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-one, method for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 2001-05-02 | — | — | EP | disclosed |
| US-6127411-A | USE AGAINST PHYTOPHTHORA INFESTANS ON OR IN POTATO PLANTS OR TUBERS; APPLYING TO SEEDS OR TUBERS A MIXTURE OF A 2-ALKOXYIMINOACETAMIDE, AN ALKYLENE BIS-DITHIOCARBAMATE COMPLEX SALT AND A THIOPHANATE | GUSTAFSON, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6020368-A | MICROBIOCIDES | HINKS JEREMY DAVID (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0874809-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997025309-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1997-07-17 | — | — | WO | disclosed |
| US-5559120-A | IMMUNOSUPPRESSANTS, ANTIINFLAMMATORY AGENTS, FUNGICIDES AND ANTITUMOR AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-09-24 | — | — | US | disclosed |
| US-5530121-A | IMMUNOSUPPRESSANTS, ANTIINFLAMMATORY AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-06-25 | — | — | US | disclosed |
| US-5530007-A | ANTITUMOR, ANTIINFLAMMATORY, ANTIFUNGAL, ANTIPROLIFERATIVE, IMMUNOSUPPRESSIVE AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-06-25 | — | — | US | disclosed |
| EP-0555628-B1 | Process for preparing isocyanates | NIPPON CATALYTIC CHEM IND (JP) | 1996-05-29 | — | — | EP | disclosed |
| US-5508399-A | USEFUL AS IMMUNOSUPPRESSANT, ANTIINFLAMMATORY, ANTIFUNGAL, ANTIPROLIFERATIVE AND ANTIUMOR AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| US-5488160-A | LEUKOTRIENE B4 RECEPTOR ANTAGONIST AS ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1996-01-30 | — | — | US | disclosed |
| US-5480989-A | Carbamates of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| US-5451700-A | Leukotriene inhibitors | CIBA-GEIGY CORPORATION (US) | 1995-09-19 | — | — | US | disclosed |
| EP-0518819-B1 | Amidino compounds, their manufacture and use as medicament | CIBA GEIGY AG (CH) | 1995-08-02 | — | — | EP | disclosed |
| US-5326903-A | Thermal decomposition of carbamate | NIPPON SHOKUBAI CO., LTD. (JP) | 1994-07-05 | — | — | US | disclosed |
| EP-0219756-B1 | Acrylic amides | SHELL INT RESEARCH (NL) | 1994-01-05 | — | — | EP | disclosed |
| EP-0555628-A2 | Process for preparing isocyanates | NIPPON SHOKUBAI CO., LTD. (JP) | 1993-08-18 | — | — | EP | disclosed |
| WO-1993009108-A1 | AMINO ACYL AMINO PROPARGYL DIOL COMPOUNDS FOR TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1993-05-13 | — | — | WO | disclosed |
| EP-0518819-A2 | Amidino compounds, their manufacture and use as medicament | CIBA-GEIGY AG (CH) | 1992-12-16 | — | — | EP | disclosed |
| US-4910200-A | Agricultural fungicide | CELAMERCK GMBH & CO. KG (DE) | 1990-03-20 | — | — | US | disclosed |
| EP-0120321-B1 | ACRYLIC-ACID AMIDES, THEIR PREPARATION AND USE | Shell Agrar GmbH & Co. KG (DE) | 1988-10-05 | — | — | EP | disclosed |
| US-4753934-A | Acrylic acid heterocyclic amides, fungicidal compositions and use | CELAMERCK GMBH & CO. KG (DE) | 1988-06-28 | — | — | US | disclosed |
| US-4400312-A | WATER, A HYDROXIDE, AND A DIALKYLAMINO DITHIO CARBAMIC ACID, A MERCAPTO ALKANONE, OR A 3-HYDROXYTHIETANE | PHILLIPS PETROLEUM COMPANY (US) | 1983-08-23 | — | — | US | disclosed |
| US-4108885-A | Salts of thiocarbamic esters with fungicidal and fungistatic action | SCHERING AG (DE) | 1978-08-22 | — | — | US | disclosed |
| US-4108885-A | Salts of thiocarbamic esters with fungicidal and fungistatic action | SCHERING AG (DE) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (21 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247264-A1 | Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma | NR3C1, NR3C2, LTB4R2 | DNM1 4430/4885KDM4E 2328/4885PAOX 844/4885 |
| US-20030144542-A1 | Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure | REN, AGTR1, GRHPR | DNM1 735/4885KDM4E 724/4885PAOX 419/4885 |
| US-20140037573-A1 | CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS | SYNCRIP, EXOSC5, EXOSC9 | DNM1 799/4885KDM4E 4539/4885PAOX 3016/4885 |
| US-20040138262-A1 | Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders | NR3C1, MC2R, FPR1 | DNM1 3125/4885KDM4E 4711/4885PAOX 1958/4885 |
| US-20220204485-A1 | STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS | TTR, MAP1LC3B, SAAL1 | DNM1 2262/4885KDM4E 4575/4885PAOX 4238/4885 |
| US-20030135066-A1 | Use of propargyl glycine amino propargyl diol compounds for treatment of congestive heart failure | REN, AGTR1, AGTR2 | DNM1 942/4885KDM4E 1257/4885PAOX 698/4885 |
| US-20170007702-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | NPC1L1, LIPA, LDLR | DNM1 1380/4885KDM4E 4445/4885PAOX 1629/4885 |
| US-20200306378-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | NPC1L1, LIPA, LDLR | DNM1 1380/4885KDM4E 4445/4885PAOX 1629/4885 |
| US-20210061813-A1 | NOVEL TRICYCLIC COMPOUNDS | CYP11B2, CYP11B1, ABCB1 | DNM1 4588/4885KDM4E 4131/4885PAOX 2410/4885 |
| US-20230109183-A1 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | NPC1L1, LIPA, LDLR | DNM1 1380/4885KDM4E 4445/4885PAOX 1629/4885 |
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | ZC3HAV1, SARS1, ZC3HAV1L | DNM1 1902/4885KDM4E 2111/4885PAOX 4068/4885 |
| US-11236071-B1 | Farnesoid X receptor agonists and uses thereof | NR1H4, NR1H2, NR1H3 | DNM1 1208/4885KDM4E 4790/4885PAOX 116/4885 |
| US-20030130522-A1 | Use of propargyl glycine amino propargyl diol compounds for prevention of hypertension | REN, AGTR1, GRHPR | DNM1 998/4885KDM4E 755/4885PAOX 408/4885 |
| US-20160222020-A1 | NOVEL TRICYCLIC COMPOUNDS | CYP11B2, CYP11B1, ABCB1 | DNM1 4588/4885KDM4E 4131/4885PAOX 2410/4885 |
| US-20170204076-A1 | SYNTHESIS AND USE OF AMINO LIPIDS | ACSL4, PYM1, LPAR4 | DNM1 1719/4885KDM4E 389/4885PAOX 125/4885 |
| US-20110311474-A1 | Novel Tricyclic Compounds | CYP11B2, CYP11B1, ABCB1 | DNM1 4588/4885KDM4E 4131/4885PAOX 2410/4885 |
| US-20130216497-A1 | NOVEL TRICYCLIC COMPOUNDS | CYP11B2, CYP11B1, ABCB1 | DNM1 4588/4885KDM4E 4131/4885PAOX 2410/4885 |
| US-10561732-B2 | Trialkyl cationic lipids and methods of use thereof | NPC1L1, LIPA, LDLR | DNM1 1380/4885KDM4E 4445/4885PAOX 1629/4885 |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MET, RET, ERBB2 | DNM1 3228/4885KDM4E 1695/4885PAOX 1922/4885 |
| US-11945806-B2 | Stabilization of amyloidogenic immunoglobulin light chains | TTR, MAP1LC3B, SAAL1 | DNM1 2262/4885KDM4E 4575/4885PAOX 4238/4885 |
| US-11773121-B2 | Antiviral compounds | ZC3HAV1, SARS1, ZC3HAV1L | DNM1 1902/4885KDM4E 2111/4885PAOX 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.